Mineralys Therapeutics insider plans stock sale

Mineralys Therapeutics, Inc. is the issuer for a planned sale of common stock reported by David Rodman.

Rhea-AI Filing Summary

Mineralys Therapeutics, Inc. is the issuer for a planned sale of common stock reported by David Rodman. The notice covers up to 416 shares to be sold on 07/17/2026 through Merrill Lynch following the exercise of employee stock options using a broker-assisted cashless exercise.

The disclosure also lists multiple prior sales of Mineralys common stock by David Rodman over the preceding three months, including transactions on 04/17/2026, 05/11–05/18/2026, 06/10–06/17/2026, and 07/09–07/15/2026, each with specified share amounts and aggregate sale prices.

Key Figures

Proposed shares to be sold: 416 shares Proposed sale value: $11,016.30 Sale on 05/12/2026: 6,348 shares; $186,348.35 +3 more

6 metrics

Proposed shares to be sold 416 shares Common stock sale planned for 07/17/2026 via Merrill Lynch

Proposed sale value $11,016.30 Aggregate value for 416-share common stock sale on 07/17/2026

Sale on 05/12/2026 6,348 shares; $186,348.35 Common stock sale by David Rodman on 05/12/2026

Sale on 05/13/2026 14,056 shares; $401,789.92 Common stock sale by David Rodman on 05/13/2026

Sale on 06/15/2026 9,890 shares; $235,487.24 Common stock sale by David Rodman on 06/15/2026

Sale on 07/13/2026 14,058 shares; $387,716.51 Common stock sale by David Rodman on 07/13/2026

Key Terms

cashless exercise, employee stock options, aggregate sale price

3 terms

cashless exercise financial

"Broker assisted with cashless exercise"

A cashless exercise is a way for an option holder to convert stock options into actual shares without paying the purchase price in cash; instead they immediately give up a portion of the newly issued shares to cover the cost and any withholding taxes. Investors care because this process increases the number of shares available and can slightly dilute existing holdings, while also signaling how insiders or employees are realizing compensation without needing cash — similar to paying for a purchase by handing over part of what you just bought.

employee stock options financial

"Exercise of employee stock options"

Employee stock options are contracts that give workers the right to buy a company's shares at a set price sometime in the future, like a coupon that lets you purchase stock at today’s price later on. Investors care because they align employees’ incentives with company performance and create a potential future claim on shares that can reduce existing owners’ percentage and add to a company’s reported compensation costs.

aggregate sale price financial

"each with specified share amounts and aggregate sale prices"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Mineralys Therapeutics (MLYS) Form 144 filing disclose?

It discloses that David Rodman plans to sell 416 shares of Mineralys Therapeutics common stock on 07/17/2026 after exercising employee stock options, and lists several prior common stock sales over the past three months with dates, share counts, and total proceeds.

How many Mineralys Therapeutics (MLYS) shares are proposed for sale?

The notice covers a proposed sale of 416 shares of Mineralys Therapeutics common stock. These shares are tied to the exercise of employee stock options and are expected to be sold on 07/17/2026 through Merrill Lynch using a broker-assisted cashless exercise.

What is the reported value of the new 416-share Mineralys (MLYS) sale?

The planned sale of 416 shares of Mineralys common stock has an aggregate value of $11,016.30. This amount is reported alongside the trade date of 07/17/2026 and indicates the total dollar value for that specific proposed transaction.

What prior Mineralys Therapeutics (MLYS) stock sales by David Rodman are listed?

The disclosure lists several earlier common stock sales by David Rodman between 04/17/2026 and 07/15/2026, including transactions of 2,171, 6,348, 9,890, 14,056 and other share amounts, each with corresponding aggregate sale prices in U.S. dollars.

How was the Mineralys (MLYS) option exercise structured for the 416-share sale?

The 416-share transaction is linked to an exercise of employee stock options for Mineralys common stock. It is described as broker assisted with cashless exercise, meaning the broker facilitates the sale to cover costs and deliver net shares or proceeds as structured.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/17/2026 - 04:03 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001672659
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Mineralys Therapeutics, Inc.
SEC File Number	001-41614
Address of Issuer	150 N. RADNOR CHESTER RD. SUITE F200 RADNOR PENNSYLVANIA 19087
Phone	(888) 378-6240
Name of Person for Whose Account the Securities are To Be Sold	Rodman David Malcom
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common stock	Merrill Lynch 225 Liberty St Floor 37 New York NY 10281	416	11016.30	82498101	07/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/17/2026	Exercise of employee stock options	Mineralys Therapeutics, Inc.			416	07/17/2026	Broker assisted with cashless exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	04/17/2026	416	13033.28
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	05/11/2026	2171	64500.41
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	05/12/2026	6348	186348.35
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	05/13/2026	14056	401789.92
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	05/18/2026	417	11488.35
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	06/10/2026	2170	54250.00
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	06/12/2026	6349	151901.37
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	06/15/2026	9890	235487.24
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	06/17/2026	4584	114600.00
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	07/09/2026	2171	65781.30
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	07/13/2026	14058	387716.51
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	07/15/2026	6349	168954.55

144: Remarks and Signature

Remarks
Date of Notice	07/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/29/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	David Rodman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)